CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Equity of Non-controlling Interest	Total
Stockholders' equity, Beginning balance at Feb. 01, 2020	$ 82	$ 452,833	$ (434,221)		$ 18,694
Common Stock, Shares, Outstanding period beginning at Feb. 01, 2020	8,208,227
Net loss			(6,828)		(6,828)
Common stock issuances pursuant to equity compensation awards, Value	$ 1	(3)			(2)
Common stock issuances pursuant to equity compensation awards, Shares	32,652
Share-based payment compensation		615			615
Common stock and warrant issuance, Value	$ 7	1,418			1,425
Common stock and warrant issuance, Shares	731,937
Stockholders' equity, ending balance at May. 02, 2020	$ 90	454,863	(441,049)		13,904
Common Stock, Shares, Outstanding period end at May. 02, 2020	8,972,816
Stockholders' equity, Beginning balance at Jan. 30, 2021	$ 130	474,375	(447,455)		$ 27,050
Common Stock, Shares, Outstanding period beginning at Jan. 30, 2021	13,019,061				13,019,061
Net loss			(3,228)	$ (150)	$ (3,378)
Common stock issuances pursuant to equity compensation awards, Value	$ 1	(262)			(261)
Common stock issuances pursuant to equity compensation awards, Shares	76,341
Share-based payment compensation		668			668
Common stock and warrant issuance, Value	$ 33	21,191			21,224
Common stock and warrant issuance, Shares	3,289,000
Investment of non-controlling interest				3,430	3,430
Stockholders' equity, ending balance at May. 01, 2021	$ 164	$ 495,972	$ (450,683)	$ 3,280	$ 48,733
Common Stock, Shares, Outstanding period end at May. 01, 2021	16,384,402				16,384,402